FDA Commissioner Marty Makary’s pledge to reexamine the safety of medication abortion isn’t just pointless — it’s dangerous.

HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone​," but experts say concerns ...

Lawmakers may have had Ivermectin in mind when they passed a law to safeguard doctors who prescribe off-label. But a judge on ...

Pro-life movement faces challenges as abortions remain frequent after Dobbs, focusing on defunding Planned Parenthood, ...

The number of abortions in the United States grew to 1.14 million last year — driven in part by access to abortion pills via ...

Wade and conservative states rushed to pass strict new abortion bans or revive old ones still on the books but unenforceable ...

Plaintiffs argued the statute would indirectly ban abortion medications by threatening providers with disciplinary action for ...

Three years after the Dobbs decision, the legal challenges continue for activists on both sides of the abortion debate.

The attorneys general of New York, California, Massachusetts and New Jersey on Thursday asked the US Food and Drug Administration (FDA) to remove some of the restrictions on access to mifepristone, ...

Four blue states are asking the U.S. Food and Drug Administration to remove restrictions on a key abortion medication and make it easier for clinicians to prescribe and dispense it — an attempt ...

The Trump administration on rescinded a Biden policy protecting emergency abortions at hospitals, even in states that have ...

June 4 (UPI) --Food and Drug Administration Commissioner Marty Makary said he plans to review the safety of abortion drug mifepristone after a recent study raised concerns about medical side ...